Consultant

Toll Brothers Announces its Two New Home Collections at The Enclave at The Woodlands are Selling Quickly in Spring, Texas

Retrieved on: 
Thursday, March 14, 2024
Toll Brothers, Enclave and exclave, Restaurant, The Enclave, Consultant, Design studio, Collection, Villa, The, Tomball Independent School District, Mail order

THE WOODLANDS, Texas, March 14, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, announced two new collections of single-family homes at The Enclave at The Woodlands in The Woodlands, Texas.

Key Points: 
  • THE WOODLANDS, Texas, March 14, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, announced two new collections of single-family homes at The Enclave at The Woodlands in The Woodlands, Texas.
  • The Toll Brothers Sales Center and new model home are now open daily for tours at 8134 Allston Village Trail in The Woodlands.
  • The collections offer 3 to 5 bedrooms, 2 to 4.5 bathrooms, and 2- or 3-car garages, each built with Toll Brothers’ outstanding quality, craftsmanship, and value.
  • For more information on The Enclave at The Woodlands and Toll Brothers communities in Texas, call 833-289-8655 or visit TollBrothers.com/TX .

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update

Retrieved on: 
Thursday, March 14, 2024
SIV, Data, Combination, EGFR, Property, SPI, Patient, Sale, Attention deficit hyperactivity disorder, Syndrome, Lung cancer, IND, Myelodysplastic syndrome, Bank statement, Investment, Note, European, TNBC, ADHD, GAP, BioLite, DSM-IV codes, GMP, Investigational New Drug, MDS, Common stock, UCSF, NSCLC, Dietary supplement, Research, Good manufacturing practice, Cancer, University, Security (finance), Pancreatic cancer, Drug development, TGA, FDA, Map, Consultant, Variable, Toxicity, Metastasis, Patent, MDD, Triple-negative breast cancer, License, Long-term care, Net, US FDA, Pharmaceutical industry

As per the respective agreements, each of ABVC and BioLite received 23 million shares of AIBL stock (with an expected value of $10 per share).

Key Points: 
  • As per the respective agreements, each of ABVC and BioLite received 23 million shares of AIBL stock (with an expected value of $10 per share).
  • The Company entered a cooperation agreement on August 14, 2023, with Zhong Hui Lian He Ji Tuan, Ltd. (“Zhonghui”).
  • On February 06, 2024, ABVC acquired an additional real estate asset via an equity transfer of 703,495 shares at $3.50 per share to develop plant factories for ABVC’s botanical pipeline.
  • ABVC hopes the property will ultimately be used as an integrated platform for the global development of the Asian healthcare business and the medical, pharmaceutical, and biotechnology industries.

45Drives Launches "Proxinator", Deepens Partnership with Proxmox

Retrieved on: 
Thursday, March 14, 2024
VMware ESXi, Risk, Consultant, Finger, Organization, Red Hat, Software, Linux, Online shopping

SYDNEY, Nova Scotia, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- In today’s turbulent enterprise technology market, 45Drives, the leader in open-source, big, strong, fast and secure data storage solutions, continues to thrive in market headwinds and power forward rapid innovation for enterprise. Today, the Company is thrilled to announce the launch of its new product, the Proxinator™: the ultimate open-source for enterprise virtualization solution. 

Key Points: 
  • Today, the Company is thrilled to announce the launch of its new product, the Proxinator ™: the ultimate open-source for enterprise virtualization solution.
  • Pre-installed with Linux and Proxmox, this robust unit simplifies virtual machine and storage management for peak efficiency in any use case.
  • Recently, 45Drives officially partnered with Proxmox , an open-source virtualization platform designed for enterprise-level virtualization.
  • Enterprise can rest easy with confidence that 45Drives is by far the most deeply and seamlessly integrated official Proxmox solution available today.

Toll Brothers Announces New Luxury Waterfront Community, Lakemont, Coming Soon to Hudson, Massachusetts

Retrieved on: 
Thursday, March 14, 2024
Old Country Road, Consultant, Design studio, Recreation, Toll Brothers, Bath, Mail order

HUDSON, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest single-family home community is coming soon to Hudson, Massachusetts.

Key Points: 
  • HUDSON, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest single-family home community is coming soon to Hudson, Massachusetts.
  • Lakemont by Toll Brothers will offer the rare opportunity to own a new construction home with waterfront views.
  • Toll Brothers homeowners will enjoy waterfront views and access to a boat launch less than a mile from the community.
  • “Lakemont is an exquisite community offering home buyers the Toll Brothers quality and craftsmanship that we’re known for, plus an incredible waterfront location,” said Dave Bauer, Division President of Toll Brothers in Massachusetts.

American Lithium Receives NASDAQ Notice of Minimum Price Deficiency and Clarifies Previous Engagement with New Era Publishing Inc.

Retrieved on: 
Wednesday, March 13, 2024
Lithium, Failure, Health, Administration, Mining, TSX Venture Exchange, Exchange, Geology, Notice, Knowledge, News, TLC, MINEM, Insurance, Dispute resolution, Accident, Supreme court, Macusani, Superior court, Calendar, INGEMMET, Government, Consultant, Legislation

The Notice does not have any impact on the listing of the Company's common shares on the TSX Venture Exchange.

Key Points: 
  • The Notice does not have any impact on the listing of the Company's common shares on the TSX Venture Exchange.
  • The Company has no current engagement with New Era, nor does it presently have any intention to engage New Era to provide further services to the Company.
  • American Lithium is actively engaged in the development of large-scale lithium projects within mining-friendly jurisdictions throughout the Americas.
  • American Lithium was subsequently notified that INGEMMET and MINEM have filed petitions to the Supreme Court of Peru to assume jurisdiction in the proceedings.

Toll Brothers Announces Last Chance to Purchase in Diamond Canyon Community in Pleasanton, California

Retrieved on: 
Wednesday, March 13, 2024
Diamond, BART, Pleasanton Unified School District, Consultant, Design studio, Region, Pacific Ocean, Culture, Golf, Toll Brothers, Restaurant

Only six homes remain available at Diamond Canyon, a highly sought-after community nestled within an established tree-lined neighborhood.

Key Points: 
  • Only six homes remain available at Diamond Canyon, a highly sought-after community nestled within an established tree-lined neighborhood.
  • Toll Brothers homes in Diamond Canyon feature approximately 4,000 to 4,600+ square feet of luxury living space with 5 bedrooms, 5.5 bathrooms, and 3-car garages on expansive home sites.
  • Diamond Canyon offers residents an unbeatable location with access to public and private schools within the award-winning Pleasanton Unified School District.
  • For more information and to schedule an appointment to tour Diamond Canyon and the Toll Brothers model home, call (844) 790-5263 or visit LiveDiamondCanyon.com .

Toll Brothers Announces New Luxury Home Community, Montrose at Innisbrook, Coming Soon to Palm Harbor, Florida

Retrieved on: 
Wednesday, March 13, 2024
Toll Brothers, Salamander, Tennis, Tampa Bay, Pinellas County Schools, Restaurant, Tampa Bay area, Consultant, Design studio, PGA, Golf, Hotel

PALM HARBOR, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the Montrose at Innisbrook community is coming soon to the acclaimed Innisbrook Golf Resort in Palm Harbour, Florida, which annually hosts a PGA TOUR event.

Key Points: 
  • PALM HARBOR, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the Montrose at Innisbrook community is coming soon to the acclaimed Innisbrook Golf Resort in Palm Harbour, Florida, which annually hosts a PGA TOUR event.
  • Construction of the Toll Brothers Sales Center and model homes is set to begin in the summer of 2024 and sales will start this fall.
  • The gated community will feature Toll Brothers’ stunning architectural designs with spacious single-family homes and low-maintenance townhomes ranging from 2,097 to 3,932+ square feet of luxury living space.
  • For more information on Montrose at Innisbrook and Toll Brothers communities throughout Florida, call (855) 600-8655 or visit TollBrothers.com/FL .

Intech Investment Management Announces Turnaround Two Years Post-Buyout, as Featured in Pensions & Investments

Retrieved on: 
Wednesday, March 13, 2024
Intech, Investment, PALM, Head, Culture, Crain Communications, Growth, Consultant, Pension

Two years following the management buyout, the company has made strides in reshaping its operations, as recently featured in a prominent article by Pensions & Investments.

Key Points: 
  • Two years following the management buyout, the company has made strides in reshaping its operations, as recently featured in a prominent article by Pensions & Investments.
  • Under the leadership of CEO Jose Marques, Intech has undergone a comprehensive transformation, addressing challenges head-on and pivoting towards a future-focused strategy.
  • Key initiatives have included overhauling the investment team, reducing trading costs, and refining investment models to better align with market dynamics.
  • The firm continues to explore new strategies and opportunities, aiming to stay at the forefront of the investment management industry.

NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia

Retrieved on: 
Wednesday, March 13, 2024
TENS, Fibromyalgia, Label, Patient, Contraindication, Sleep, Sale, Rehabilitation, Physical medicine and rehabilitation, Consultant, Pain

WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in December 2022.

Key Points: 
  • WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in December 2022.
  • “We have been pleased by the positive response to Quell Fibromyalgia from providers taking care of patients with fibromyalgia during our strategic launch phase,” said Shai N. Gozani, M.D., Ph.D., Chief Executive Officer of NeuroMetrix.
  • In my practice, we have even had some patients report they were able to reduce pain with Quell Fibromyalgia that medications have never helped before."
  • The sale, distribution, and use of Quell Fibromyalgia is restricted to prescription use in accordance with 21 CFR 801.109.

MetrioPharm Establishes Scientific Advisory Board of Seasoned Immunology and Pediatric Experts

Retrieved on: 
Wednesday, March 13, 2024
Patient, Child, Laboratory, Duchenne muscular dystrophy, University of Oxford, School, Research, Inflammation, Electrophysiology, National Science Foundation, Immunology, Rockefeller University, Research fellow, Neuromuscular disease, Pediatrics, Pathology, SAB, IRB, CNRS, Neurology, Inflammation Research, Surgery, University, Neuro, MD, Senior, Consultant, Chemokine, Medical school, Retirement, CSO, Myopathy, Signal transduction, Doctor of Philosophy, Nursing

Ferdinando Nicoletti, MD, PhD, has been Full Professor of General Pathology and Immunology since 2011 at the University of Catania (Italy).

Key Points: 
  • Ferdinando Nicoletti, MD, PhD, has been Full Professor of General Pathology and Immunology since 2011 at the University of Catania (Italy).
  • “We welcome the members of MetrioPharm’s newly established scientific advisory board,” said Thomas Christély, CEO of MetrioPharm.
  • “We are happy to now formally establish and introduce this panel of experts for an even closer collaboration.
  • Every aspect of our research development program - from preclinical research to clinical trials - will benefit from the unparalleled expertise of our new scientific advisors.”